Literature DB >> 24101784

Why the time is right to tackle breast and cervical cancer in low-resource settings.

Vivien Davis Tsu1, Jose Jeronimo, Benjamin O Anderson.   

Abstract

The health concerns of women in their mid-adult years - when the prime age of reproduction has passed - have been traditionally given little or no attention by health systems and donors, despite the heavy burden that diseases such as breast and cervical cancer impose on women and their families. The risk of sexually transmitted infections that accompanies sexual relations and the risk of death and morbidity associated with pregnancy have long been recognized and have stimulated major control efforts that are finally yielding positive results. Much less attention has been focused, however, on how experiences in early life can affect women's health in adulthood. Breast and cervical cancers kill more women than any other types of cancer in all parts of the developing world. In most of Asia and Latin America and some African countries, deaths from these two forms of cancer now outnumber pregnancy-related deaths. There are five compelling reasons for focusing on these cancers now to try to reverse these epidemiologic trends: (i) the burden of breast and cervical cancer is large and is growing; (ii) effective screening and treatment are available; (iii) research is generating new knowledge; (iv) there are opportunities for synergy with other health programmes; and (v) noncommunicable diseases are the focus of much current interest.

Entities:  

Mesh:

Year:  2013        PMID: 24101784      PMCID: PMC3790214          DOI: 10.2471/BLT.12.116020

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  34 in total

1.  Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction.

Authors:  Jessica A Kahn; Darron R Brown; Lili Ding; Lea E Widdice; Marcia L Shew; Susan Glynn; David I Bernstein
Journal:  Pediatrics       Date:  2012-07-09       Impact factor: 7.124

2.  Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial.

Authors:  Rengaswamy Sankaranarayanan; Pulikkottil Okkuru Esmy; Rajamanickam Rajkumar; Richard Muwonge; Rajaraman Swaminathan; Sivanandam Shanthakumari; Jean-Marie Fayette; Jacob Cherian
Journal:  Lancet       Date:  2007-08-04       Impact factor: 79.321

3.  Clinical breast examination: preliminary results from a cluster randomized controlled trial in India.

Authors:  Rengaswamy Sankaranarayanan; Kunnambath Ramadas; Somanathan Thara; Richard Muwonge; Jem Prabhakar; Paul Augustine; Muraleedharan Venugopal; Gopan Anju; Beela Sara Mathew
Journal:  J Natl Cancer Inst       Date:  2011-08-23       Impact factor: 13.506

4.  Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study.

Authors:  Julia M L Brotherton; Masha Fridman; Cathryn L May; Genevieve Chappell; A Marion Saville; Dorota M Gertig
Journal:  Lancet       Date:  2011-06-18       Impact factor: 79.321

5.  Breast cancer screening in developing countries.

Authors:  Indraneel Mittra
Journal:  Prev Med       Date:  2011-06-25       Impact factor: 4.018

6.  Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007.

Authors:  Benjamin O Anderson; Cheng-Har Yip; Robert A Smith; Roman Shyyan; Stephen F Sener; Alexandru Eniu; Robert W Carlson; Edward Azavedo; Joe Harford
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.860

Review 7.  Breast cancer prevention in countries with diverse resources.

Authors:  Anne McTiernan; Peggy Porter; John D Potter
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.860

8.  HPV screening for cervical cancer in rural India.

Authors:  Rengaswamy Sankaranarayanan; Bhagwan M Nene; Surendra S Shastri; Kasturi Jayant; Richard Muwonge; Atul M Budukh; Sanjay Hingmire; Sylla G Malvi; Ranjit Thorat; Ashok Kothari; Roshan Chinoy; Rohini Kelkar; Shubhada Kane; Sangeetha Desai; Vijay R Keskar; Raghevendra Rajeshwarkar; Nandkumar Panse; Ketayun A Dinshaw
Journal:  N Engl J Med       Date:  2009-04-02       Impact factor: 91.245

Review 9.  The number of women who would need to be screened regularly by mammography to prevent one death from breast cancer.

Authors:  Valerie Beral; Maggie Alexander; Stephen Duffy; Ian O Ellis; Rosalind Given-Wilson; Lars Holmberg; Sue M Moss; Amanda Ramirez; Malcolm W R Reed; Caroline Rubin; Patsy Whelehan; Robin Wilson; Kenneth C Young
Journal:  J Med Screen       Date:  2011       Impact factor: 2.136

10.  Effectiveness, safety and acceptability of 'see and treat' with cryotherapy by nurses in a cervical screening study in India.

Authors:  R Sankaranarayanan; R Rajkumar; P O Esmy; J M Fayette; S Shanthakumary; L Frappart; S Thara; J Cherian
Journal:  Br J Cancer       Date:  2007-02-20       Impact factor: 7.640

View more
  24 in total

1.  Policy directions to improve women's health beyond reproduction.

Authors:  Flavia Bustreo; Isabelle de Zoysa; Islene Araujo de Carvalho
Journal:  Bull World Health Organ       Date:  2013-09-01       Impact factor: 9.408

2.  Demographic changes in breast cancer incidence, stage at diagnosis and age associated with population-based mammographic screening.

Authors:  Francys C Verdial; Ruth Etzioni; Catherine Duggan; Benjamin O Anderson
Journal:  J Surg Oncol       Date:  2017-02-14       Impact factor: 3.454

Review 3.  Fluorescence Imaging for Cancer Screening and Surveillance.

Authors:  K E Tipirneni; E L Rosenthal; L S Moore; A D Haskins; N Udayakumar; A H Jani; W R Carroll; A B Morlandt; M Bogyo; J Rao; Jason M Warram
Journal:  Mol Imaging Biol       Date:  2017-10       Impact factor: 3.488

4.  Mapping HPV Vaccination and Cervical Cancer Screening Practice in the Pacific Region-Strengthening National and Regional Cervical Cancer Prevention.

Authors:  J Obel; J McKenzie; L E Buenconsejo-Lum; A M Durand; A Ekeroma; Y Souares; D Hoy; W Baravilala; S M Garland; S K Kjaer; A Roth
Journal:  Asian Pac J Cancer Prev       Date:  2015

5.  Transvaginal Sonography Versus Cystoscopy for Detecting Urinary Bladder Invasion in Early Stage Cervical Cancer.

Authors:  Vijay Zutshi; Binni Makkar; Anju Garg; Swaraj Batra
Journal:  J Clin Diagn Res       Date:  2017-02-01

Review 6.  Breast cancer in sub-Saharan Africa: The current state and uncertain future.

Authors:  Claudia A Anyigba; Gordon A Awandare; Lily Paemka
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-29

7.  Life-course socioeconomic status and breast and cervical cancer screening: analysis of the WHO's Study on Global Ageing and Adult Health (SAGE).

Authors:  Tomi Akinyemiju; Kemi Ogunsina; Swati Sakhuja; Valentine Ogbhodo; Dejana Braithwaite
Journal:  BMJ Open       Date:  2016-11-22       Impact factor: 2.692

8.  Development of enhanced ethanol ablation as an alternative to surgery in treatment of superficial solid tumors.

Authors:  Robert Morhard; Corrine Nief; Carlos Barrero Castedo; Fangyao Hu; Megan Madonna; Jenna L Mueller; Mark W Dewhirst; David F Katz; Nirmala Ramanujam
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

9.  Cost-effectiveness analysis of breast cancer control interventions in Peru.

Authors:  Sten G Zelle; Tatiana Vidaurre; Julio E Abugattas; Javier E Manrique; Gustavo Sarria; José Jeronimo; Janice N Seinfeld; Jeremy A Lauer; Cecilia R Sepulveda; Diego Venegas; Rob Baltussen
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

10.  Cellphone enabled point-of-care assessment of breast tumor cytology and molecular HER2 expression from fine-needle aspirates.

Authors:  Daniel Y Joh; Jacob T Heggestad; Shengwei Zhang; Gray R Anderson; Jayanta Bhattacharyya; Suzanne E Wardell; Simone A Wall; Amy B Cheng; Faris Albarghouthi; Jason Liu; Sachi Oshima; Angus M Hucknall; Terry Hyslop; Allison H S Hall; Kris C Wood; E Shelley Hwang; Kyle C Strickland; Qingshan Wei; Ashutosh Chilkoti
Journal:  NPJ Breast Cancer       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.